Vaccines

Value Communications

Access comprehensive, tailored communication solutions

Personalized vaccine communication strategy

Access our wide range of value communication solutions, tailored to your vaccine, and designed to deliver commercial success.

Alira Health’s in-house team works closely with you to create a detailed, personalized communication strategy that outlines the differentiating factors of your vaccine.
Our multidisciplinary, industry-leading approach includes:
  • Developing payer value propositions and value dossiers
  • Identifying indication-specific opportunities related to epidemiological situation and burden of disease
  • Highlighting specific value (e.g., MoA, clinical benefit, epidemiology)
  • Defining competitive access positioning in different patient groups, age groups, and market segments
  • Demonstrating robust economic and societal value
  • Developing communication tools to support vaccine uptake

Why choose Alira Health?

As our partner, you’ll benefit from our:

  • Focused attention on your specific needs, individual aspects of your vaccine, and corporate communication strategy
  • In-house industry experts with over 25 years of experience working with the key market stakeholders—from payers to doctors
  • In-depth knowledge and understanding of local and global market dynamics and and communication channels

Working together to transform healthcare

Whether you need to understand which asset best aligns with your long-term strategy, which new market or therapeutic area to explore, or how to expand into another sector, we are ready to help you lead the way.

Contact us
Bernd Schollmeier
Bernd Shollmier
Vice President of Global Market Access Vaccines
We are seeing a lot of traction in the industry, as well as interest in vaccine production. To support companies in a challenging payer environment, we created a dedicated vaccine division in our Global Market Access department to provide a variety of solutions that maximize patient access and the gross-to-net value of the product across the full product lifecycle.

Related News

Blog April 17, 2024
The Challenges for Medtech in a Complex Regulatory Landscape in 2024
Learn more about what manufacturers in the US and Europe should consider when developing their regulatory strategies and prioritizing their target markets from regulatory affairs expert Mercè Guerra.
Medical Devices MedTech Regulatory
Blog March 18, 2024
WHO Model Lists of Essential Medicines: What You Need to Know 
Our Market Access experts share the importance of the EML for pharma companies and four best practices for a successful application, based on our extensive experience in interactions with the WHO.
Market Access
Events March 7, 2024
MedTech Impact Symposium & Gala 2024
Look for us at the 2024 MassMedic Medtech Impact Symposium and let's connect on the four focus tracks: Maternal Health, Cardiac Health, Diabetes and Musculoskeletal Health.
Medical Devices MedTech
Blog February 27, 2024
The 2024 Global Medtech Contract Manufacturing Report: Executive Summary
Executive summary of our 2024 global medtech contract manufacturing report detailing global trends and investment activity and in-depth analysis of the European outsourcing market.
CDMO MedTech
News February 26, 2024
Alira Health Releases The 2024 Global Medtech Contract Manufacturing Report
Alira Health announced the release of the 2024 Global Medtech Contract Manufacturing Report. This report offers a comprehensive analysis of trends in the global medtech contract manufacturing(...)
CDMO MedTech
Publications February 25, 2024
The 2024 Global Medtech Contract Manufacturing Report
Discover the trends in the world of medical device CDMOs and their meaning for the industry in 2024 and beyond.
CDMO MedTech
Multimedia February 22, 2024
Robotic-assisted Surgery in Orthopedic Procedures: Current Landscape and 2024 Outlook
This webinar replay investigates the current RAS landscape with specific focus on adoption drivers, market dynamics, access challenges and more.
MedTech Orthopedic Robotic-Assisted Surgery (RAS)
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.